{
  "trial_id": "NCT00498719",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "at least 6-years-old",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "enrolled in school or homebound instruction in a grade Kindergarten through 12th.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "A diagnosis of leukemia, lymphoma, or brain tumor (e.g., primary brain tumors, leptomeningeal infiltration, or metastases) that requires treatment of the CNS (surgery, CRT, and/or chemotherapy).",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Within 2 months to 14 months after beginning treatment for cancer.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Full scale IQ > or = 70.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "English-speaking. (This is defined as the ability to appropriately respond to test and training materials.)",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "A major physical, neurologic, or psychiatric condition that would preclude participation comprehend training materials and therapeutic interventions.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "unknown",
      "label": "unknown",
      "evidence": "quote"
    }
  ],
  "notes": "The patient has Hashimoto disease, but it does not seem to be a major condition that would preclude participation. She is also English-speaking.",
  "_meta": {
    "topic_id": "66",
    "trial_id": "NCT00498719",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}